Bactericidal permeability-increasing protein (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bactericidal permeability-increasing protein" in English language version.

refsWebsite

Global rank English rank

12nih.gov

4^th place

7doi.org

2^nd place

2semanticscholar.org

11^th place

8^th place

2harvard.edu

18^th place

17^th place

1uniprot.org

5,673^rd place

6,418^th place

doi.org

Elsbach P (July 1998). "The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense". Journal of Leukocyte Biology. 64 (1). Wiley-Liss: 14–8. doi:10.1002/jlb.64.1.14. PMID 9665269. S2CID 36780757.
Canny G, Levy O, Furuta GT, Narravula-Alipati S, Sisson RB, Serhan CN, Colgan SP (March 2002). "Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia". Proceedings of the National Academy of Sciences of the United States of America. 99 (6). National Academy of Sciences: 3902–7. Bibcode:2002PNAS...99.3902C. doi:10.1073/pnas.052533799. PMC 122621. PMID 11891303.
Levin M, Quint PA, Goldstein B, Barton P, Bradley JS, Shemie SD, Yeh T, Kim SS, Cafaro DP, Scannon PJ, Giroir BP (September 2000). "Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group". Lancet. 356 (9234). Lancet Publishing Group: 961–7. doi:10.1016/S0140-6736(00)02712-4. PMID 11041396. S2CID 40877544.
Schlag G, Redl H, Davies J, Scannon P (February 1999). "Protective effect of bactericidal/permeability-increasing protein (rBPI21) in baboon sepsis is related to its antibacterial, not antiendotoxin, properties". Annals of Surgery. 229 (2). Lippincott Williams & Wilkins: 262–71. doi:10.1097/00000658-199902000-00015. PMC 1191640. PMID 10024109.
Srivastava A, Casey H, Johnson N, Levy O, Malley R (January 2007). "Recombinant bactericidal/permeability-increasing protein rBPI21 protects against pneumococcal disease". Infection and Immunity. 75 (1). American Society for Microbiology: 342–9. doi:10.1128/IAI.01089-06. PMC 1828387. PMID 17101667.
Khan AA, Lambert LH, Remington JS, Araujo FG (April 1999). "Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii". Antimicrobial Agents and Chemotherapy. 43 (4). American Society for Microbiology: 758–62. doi:10.1128/aac.43.4.758. PMC 89203. PMID 10103177.
Balakrishnan A, DasSarma P, Bhattacharjee O, Kim JM, DasSarma S, Chakravortty D (September 2016). "Halobacterial nano vesicles displaying murine bactericidal permeability-increasing protein rescue mice from lethal endotoxic shock". Scientific Reports. 6: 33679. Bibcode:2016NatSR...633679B. doi:10.1038/srep33679. PMC 5028748. PMID 27646594.

harvard.edu

ui.adsabs.harvard.edu

Canny G, Levy O, Furuta GT, Narravula-Alipati S, Sisson RB, Serhan CN, Colgan SP (March 2002). "Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia". Proceedings of the National Academy of Sciences of the United States of America. 99 (6). National Academy of Sciences: 3902–7. Bibcode:2002PNAS...99.3902C. doi:10.1073/pnas.052533799. PMC 122621. PMID 11891303.
Balakrishnan A, DasSarma P, Bhattacharjee O, Kim JM, DasSarma S, Chakravortty D (September 2016). "Halobacterial nano vesicles displaying murine bactericidal permeability-increasing protein rescue mice from lethal endotoxic shock". Scientific Reports. 6: 33679. Bibcode:2016NatSR...633679B. doi:10.1038/srep33679. PMC 5028748. PMID 27646594.

nih.gov

pubmed.ncbi.nlm.nih.gov

Elsbach P (July 1998). "The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense". Journal of Leukocyte Biology. 64 (1). Wiley-Liss: 14–8. doi:10.1002/jlb.64.1.14. PMID 9665269. S2CID 36780757.
Canny G, Levy O, Furuta GT, Narravula-Alipati S, Sisson RB, Serhan CN, Colgan SP (March 2002). "Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia". Proceedings of the National Academy of Sciences of the United States of America. 99 (6). National Academy of Sciences: 3902–7. Bibcode:2002PNAS...99.3902C. doi:10.1073/pnas.052533799. PMC 122621. PMID 11891303.
Levin M, Quint PA, Goldstein B, Barton P, Bradley JS, Shemie SD, Yeh T, Kim SS, Cafaro DP, Scannon PJ, Giroir BP (September 2000). "Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group". Lancet. 356 (9234). Lancet Publishing Group: 961–7. doi:10.1016/S0140-6736(00)02712-4. PMID 11041396. S2CID 40877544.
Schlag G, Redl H, Davies J, Scannon P (February 1999). "Protective effect of bactericidal/permeability-increasing protein (rBPI21) in baboon sepsis is related to its antibacterial, not antiendotoxin, properties". Annals of Surgery. 229 (2). Lippincott Williams & Wilkins: 262–71. doi:10.1097/00000658-199902000-00015. PMC 1191640. PMID 10024109.
Srivastava A, Casey H, Johnson N, Levy O, Malley R (January 2007). "Recombinant bactericidal/permeability-increasing protein rBPI21 protects against pneumococcal disease". Infection and Immunity. 75 (1). American Society for Microbiology: 342–9. doi:10.1128/IAI.01089-06. PMC 1828387. PMID 17101667.
Khan AA, Lambert LH, Remington JS, Araujo FG (April 1999). "Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii". Antimicrobial Agents and Chemotherapy. 43 (4). American Society for Microbiology: 758–62. doi:10.1128/aac.43.4.758. PMC 89203. PMID 10103177.
Balakrishnan A, DasSarma P, Bhattacharjee O, Kim JM, DasSarma S, Chakravortty D (September 2016). "Halobacterial nano vesicles displaying murine bactericidal permeability-increasing protein rescue mice from lethal endotoxic shock". Scientific Reports. 6: 33679. Bibcode:2016NatSR...633679B. doi:10.1038/srep33679. PMC 5028748. PMID 27646594.

ncbi.nlm.nih.gov

Canny G, Levy O, Furuta GT, Narravula-Alipati S, Sisson RB, Serhan CN, Colgan SP (March 2002). "Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia". Proceedings of the National Academy of Sciences of the United States of America. 99 (6). National Academy of Sciences: 3902–7. Bibcode:2002PNAS...99.3902C. doi:10.1073/pnas.052533799. PMC 122621. PMID 11891303.
Schlag G, Redl H, Davies J, Scannon P (February 1999). "Protective effect of bactericidal/permeability-increasing protein (rBPI21) in baboon sepsis is related to its antibacterial, not antiendotoxin, properties". Annals of Surgery. 229 (2). Lippincott Williams & Wilkins: 262–71. doi:10.1097/00000658-199902000-00015. PMC 1191640. PMID 10024109.
Srivastava A, Casey H, Johnson N, Levy O, Malley R (January 2007). "Recombinant bactericidal/permeability-increasing protein rBPI21 protects against pneumococcal disease". Infection and Immunity. 75 (1). American Society for Microbiology: 342–9. doi:10.1128/IAI.01089-06. PMC 1828387. PMID 17101667.
Khan AA, Lambert LH, Remington JS, Araujo FG (April 1999). "Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii". Antimicrobial Agents and Chemotherapy. 43 (4). American Society for Microbiology: 758–62. doi:10.1128/aac.43.4.758. PMC 89203. PMID 10103177.
Balakrishnan A, DasSarma P, Bhattacharjee O, Kim JM, DasSarma S, Chakravortty D (September 2016). "Halobacterial nano vesicles displaying murine bactericidal permeability-increasing protein rescue mice from lethal endotoxic shock". Scientific Reports. 6: 33679. Bibcode:2016NatSR...633679B. doi:10.1038/srep33679. PMC 5028748. PMID 27646594.

semanticscholar.org

api.semanticscholar.org

Elsbach P (July 1998). "The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense". Journal of Leukocyte Biology. 64 (1). Wiley-Liss: 14–8. doi:10.1002/jlb.64.1.14. PMID 9665269. S2CID 36780757.
Levin M, Quint PA, Goldstein B, Barton P, Bradley JS, Shemie SD, Yeh T, Kim SS, Cafaro DP, Scannon PJ, Giroir BP (September 2000). "Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group". Lancet. 356 (9234). Lancet Publishing Group: 961–7. doi:10.1016/S0140-6736(00)02712-4. PMID 11041396. S2CID 40877544.

uniprot.org

"UniProt". www.uniprot.org. Retrieved 11 June 2023.